TP53 mutation in allogeneic hematopoietic cell transplantation for de novo myelodysplastic syndrome

被引：0

作者：

Kim, Yoo-Jin ^{[1
]}

Jung, Seung-Hyun ^{[2
]}

Hur, Eun-Hye ^{[3
]}

Choi, Eun-Ji ^{[3
]}

Lee, Kyoo-Hyung ^{[3
]}

Yim, Seon-Hee ^{[2
]}

Kim, Hye-Jung ^{[1
]}

Kwon, Yong-Rim ^{[1
]}

Jeon, Young-Woo ^{[1
]}

Lee, Sug Hyung ^{[4
]}

Chung, Yeun-Jun ^{[2
]}

Lee, Je-Hwan ^{[3
]}

机构：

[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Hematol, Seoul, South Korea

[2] Catholic Univ Korea, Coll Med, Microbiol, Seoul, South Korea

[3] Univ Ulsan, Coll Med, Asan Med Ctr, Hematol, Seoul, South Korea

[4] Catholic Univ Korea, Coll Med, Pathol, Seoul, South Korea

来源：

BONE MARROW TRANSPLANTATION | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P698

引用

页码：667 / 668

页数：2

共 50 条

[1] TP53 mutation in allogeneic hematopoietic cell transplantation for de novo myelodysplastic syndrome
Kim, Yoo-Jin
Jung, Seung-Hyun
Hur, Eun-Hye
Choi, Eun-Ji
Lee, Kyoo-Hyung
Yim, Seon-Hee
Kim, Hye-Jung
Kwon, Yong-Rim
Jeon, Young-Woo
Lee, Sug Hyung
Chung, Yeun-Jun
Lee, Je-Hwan
LEUKEMIA RESEARCH, 2018, 74 : 97 - 104
[2] Impact of TP53 alteration on allogeneic hematopoietic cell transplantation outcomes for myelodysplastic syndromes
Zhou, Cuiyan
Xu, Lanping
Zhang, Xiaohui
Chang, Yingjun
Mo, Xiaodong
Sun, Yuqian
Huang, Xiaojun
Wang, Yu
BONE MARROW TRANSPLANTATION, 2025, : 467 - 473
[3] Impact of Epigenomic Hypermethylation at TP53 on Allogeneic Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndromes
Wang, Wei
Auer, Paul
Zhang, Tao
Spellman, Stephen
Carlson, Karen-Sue
Nazha, Aziz
Bolon, Yung-Tsi
Saber, Wael
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (08): : 659.e1 - 659.e6
[4] TP53 and IDH2 Somatic Mutations Are Associated with Poor Outcomes Following Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
Kharfan-Dabaja, Mohamed A.
Komrokji, Rami S.
Zhang, Qing
Sallman, David
Mishra, Asmita
Al Ali, Najla H.
Nishihori, Taiga
Field, Teresa
Salem, Karma Z.
Perkins, Janelle
Zhang, Ling
Moscinski, Lynn C.
Fernandez, Hugo F.
Lancet, Jeffrey E.
List, Alan F.
Anasetti, Claudio
Padron, Eric
BLOOD, 2015, 126 (23)
[5] Impact of TP53 Allelic State on Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasm
Jiang, Bingqian
Yang, Tingting
Luo, Yi
Zhao, Yanmin
Ouyang, Guifang
Yu, Jian
Lan, Jianping
Lu, Ying
Lai, Xiaoyu
Ye, Baodong
Chen, Yi
Liu, Lizhen
Xu, Yang
Shi, Pengfei
Xiao, Haowen
Hu, Huixian
Guo, Qunyi
Fu, Huarui
Ye, Yishan
Wang, Xinyu
Sun, Jie
Zheng, Weiyan
He, Jingsong
Zhao, Yi
Wu, Wenjun
Cai, Zhen
Wei, Guoqing
Huang, He
Shi, Jimin
BLOOD, 2023, 142
[6] Multiple Malignancies in a Child with de novo TP53 Mutation
Wozniak, Alicja
Fryer, Alan
Grimer, Robert
Mc Dowell, Heather
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (04) : 338 - 343
[7] TP53 mutations in myelodysplastic syndrome
Misawa, S
Horiike, S
LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 417 - 422
[8] TP53 Abnormality in Myelodysplastic Syndrome
Huang, Fei
Chen, Yu
Zhu, Yuxing
Qiao, Chun
Qian, Sixuan
Li, Jianyong
Shen, Wenyi
BLOOD, 2019, 134
[9] TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Marvin-Peek, Jennifer
Mason, Emily F.
Kishtagari, Ashwin
Jayani, Reena, V
Dholaria, Bhagirathbhai
Kim, Tae Kon
Engelhardt, Brian G.
Chen, Heidi
Strickland, Stephen
Savani, Bipin
Ferrell, Brent
Kassim, Adetola
Savona, Michael
Mohan, Sanjay
Byrne, Michael
TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 390.e1 - 390.e10
[10] TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Marvin-Peek, Jennifer
Kishtagari, Ashwin
Jayani, Reena
Dholaria, Bhagirathbhai
Kim, Tae Kon
Mason, Emily F.
Engelhardt, Brian G.
Chen, Heidi
Kassim, Adetola A.
Savona, Michael R.
Savani, Bipin
Byrne, Michael
BLOOD, 2022, 140 : 11638 - 11640

← 1 2 3 4 5 →